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Hemoglobin A1c (A1c) has been investigated as a target for 
treatment of diabetes. Work has been done toward the stan-
dardization of A1c measurement, and the standardized meth-
od for A1c testing produces data consistent with that of the in-
ternational A1c-Derived Average Glucose (ADAG) trial and 
Diabetes Control and Complications Trial (DCCT) [1,2]. A1c 
measurement is a more convenient and reproducible method 
than fasting glucose, providing reliable information for chron-
ic glycemic control for 2 to 3 months. A1c has been known to 
have a strong correlation with chronic complications of diabe-
tes and mortality [3,4].
  Based on this evidence, the American Diabetes Association 
(ADA) suggested revised criteria for the diagnosis of diabetes 
mellitus using A1c levels, the criteria for which was A1c ≥6.5% 
[5]. However, there has been some debate that the recent ADA 
criterion by A1c level was too high, and concern has been raised 
about the possible delay in detecting undiagnosed diabetes [6-
8]. Furthermore, it is very important to determine the appro-
priate A1c cutoff value based on epidemiology data for people 
of different ethnic backgrounds for the diagnosis of diabetes 
throughout the world.
  From our previous prospective Ansung-cohort study, 635 
participants (6.8%) had previously undiagnosed diabetes at 
baseline. An A1c cutoff value of 5.8% produced the highest 
sensitivity (72%) and specificity (86%) for detecting undiag-
nosed diabetes by receiver operating characteristic curve anal-
ysis in our cohort. At 6 years, 895 (10.2%) had developed new-
onset diabetes. The cutoff A1c of 5.8% was the most accurate 
for predicting 6-year incident diabetes. After multiple adjust-
ments, both men and women with a baseline A1c of ≥5.8% had 
a more than 3-fold increase in the risk of new-onset diabetes 
compared with those with A1c <5.8% at baseline [8]. When 
we converted this value to a DCCT-aligned assay, a cutoff of 
≥6.5% had only 52.3% sensitivity with 96.8% specificity. An 
A1c value of 6.2% as obtained from the converted value was 
best for detection of undiagnosed diabetes as defined by the 
oral glucose tolerance test criteria with 67.6% sensitivity and 
90.7% specificity.
  Kim et al. [9] concluded from an analysis of retrospective, 
routine health examination data (more than 35,000 recipients) 
that measurement of A1c alone could not detect undiagnosed 
diabetes properly in their study population (detection rate: 
18.1% by A1c only vs. 31.8% by fasting blood glucose [FBS]). 
A diagnosis made with A1c and FBS together enhanced the 
accuracy of diagnosis up to 38.1%. In conclusion, A1c criteria 
alone identifies fewer subjects with increased risk of diabetes 
than does FBS criteria, and about 20% more cases could be de-
tected by the addition of HbA1c criteria. This is an interesting 
and important result in terms of providing proper methods 
for diagnosis of diabetes in the Korean population, in spite of 
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the retrospective data from routine health care of Kim et al. In 
addition, considering FBS and A1c together produced more 
accurate results for the detection of diabetes by reflecting both 
acute and chronic hyperglycemia. However, Kim et al. only 
mentioned that A1c was measured with high-performance 
liquid chromatography in their study. We wanted to know if 
the A1c value when converted to the the DCCT-aligned refer-
ence A1c in their study. 
  Furthermore, the cohort from Ansung prospective study 
will soon begin undergoing 10-year follow up visits. We will 
be able to analyze prospective cohort data and the health ex-
amination data together to provide the best cutoff value for 
A1c and the values for both A1c and FBS together for the de-
tection of diabetes in Koreans. 
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